Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Dare Bioscience Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -162340.76%, while the net margin is -157505.13%. These profitability ratios, combined with a Return on Equity (ROE) of -2543.13%, provide a clear picture of how effectively DARE converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, DARE competes directly with industry leaders such as RVPH and SKYE. With a market capitalization of $22.36M, it holds a significant position in the sector. When comparing efficiency, DARE's gross margin of 100.00% stands against RVPH's N/A and SKYE's N/A. Such benchmarking helps identify whether Dare Bioscience Inc is trading at a premium or discount relative to its financial performance.
